Weisz et al. reported that in the lung- and breast-cancer cell lines, p53-R175H can augment the induction of NF-κB expression in response to TNFα, which is a cytokine presented in a chronic inflammation environment, thereby promoting cancer progression. Here, TP53 is linked to breast carcinoma.